Olivier Danos
CIK 1701180 · Chief Scientific Officer · last filed 2025-04-04
Olivier Danos is a Chief Scientific Officer who has filed 15 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing shows the insider had shares withheld for taxes covering $44.0K of RGNX on Apr 4, 2025. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.51M
1
15
-$1.38M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGNX | Chief Scientific Officer | 226,348 | $6.66 | $1.51M | -$1.38M | 15 | 2025-04-04 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-04 | RGNX | Tax (F) | −5,452 | -$44.0K | EDGAR |
| 2025-01-06 | RGNX | Mixed | +46,717 | -$97.6K | EDGAR |
| 2024-08-05 | RGNX | Grant (A) | +60,230 | $13.6K | EDGAR |
| 2024-01-04 | RGNX | Mixed | +31,903 | -$116.6K | EDGAR |
| 2023-01-05 | RGNX | Mixed | +63,872 | -$46.7K | EDGAR |
| 2022-01-04 | RGNX | Mixed | +10,035 | -$21.6K | EDGAR |
| 2021-01-06 | RGNX | Grant (A) | +12,543 | $30.6K | EDGAR |
| 2020-01-06 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2019-04-17 | RGNX | Mixed | — | -$64.6K | EDGAR |
| 2019-03-14 | RGNX | Exer (M) | +5,000 | $101.8K | EDGAR |